MedPath
NMPA Approval

Paracetamol,Aminophenazone,Caffeine and Chlorphenamine Maleate Tablets

国药准字H52020630

July 3, 2019

Drug Information

酚氨咖敏片

片剂

复方

化学药品

July 3, 2019

Company Information

Manufacturing Company

贵州省安顺市经济技术开发区西航路212号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酚氨咖敏片 - NMPA 批准文号 | MedPath